Table: RaQualia Pharma -2022 group results

RaQualia Pharma

14/02/2023 06:15

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2022    Dec 31, 2021   Dec 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             2.92            2.78           2.80                  
                 (+5.1 pct)     (+150.7 pct)    (-4.1 pct)               
  Operating        866 mln         707 mln        260 mln                
                 (+22.4 pct)                    (-69.9 pct)              
  Recurring        904 mln         863 mln        242 mln                
                 (+4.7 pct)                     (-73.2 pct)              
  Net
  Net              723 mln         755 mln        183 mln                
                 (-4.3 pct)                     (-74.7 pct)              
  EPS             34.50 yen       36.07 yen      8.74 yen                
  EPS Diluted     34.47 yen       36.04 yen                              
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T